tiprankstipranks
Avantor Inc (AVTR)
NYSE:AVTR
US Market
Want to see AVTR full AI Analyst Report?

Avantor (AVTR) Blogger Opinions & Sentiment

472 Followers

Blogger Sentiment

Bearish: 60.00%
Sector Average
Neutral
AVTR Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% Zacks
40% SeekingAlpha
20% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Hims & Hers stock plunges post Q2 earnings miss, gross margin down
Zacks
AVTR SWOT Analysis: Financial Resilience Amidst Challenges Revealed in 10-Q Filing
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of AVTR?
Seeking Alpha’s Dulan Lokuwithana has a Bearish Sentiment.
    What do Motley Fool contributors think of AVTR?
    Currently there's no blogger sentiment for AVTR.
    What Is AVTR’s Blogger Sentiment?
    AVTR’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for AVTR?
      The most recent blogger prediction for AVTR was made by Zacks Equity Research, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics
          SMMTSummit Therapeutics